GLOBUS MEDICAL, INC. Excess Tax Benefit from Share-based Compensation, Operating Activities
GLOBUS MEDICAL, INC. (GMED) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $1.57 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2017-11-09
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-12-31 was $71.00K, a 7.79% decline year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-09-30 was $700.00K, a 6.71% increase year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-06-30 was $300.00K, a 52.61% decline year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-03-31 was $500.00K, a 26.90% decline year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2016 was $1.57M, a 23.37% decline from fiscal 2015.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $2.05M, a 53.49% decline from fiscal 2014.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $4.41M, a 7.32% decline from fiscal 2013.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $4.76M.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month as first filed | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month as first filed | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month as first filed | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $771.00K derived: sum of 2 quarters · filed 2017-11-09 | $1.07M derived: sum of 3 quarters · filed 2017-11-09 | $1.57M 10-K · filed 2017-03-16 | |||
| 2016-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.00M derived: sum of 2 quarters · filed 2017-11-09 | $1.50M 10-Q · filed 2017-11-09 | $1.48M 10-Q · filed 2016-11-09 | $1.58M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $800.00K 10-Q · filed 2017-08-03 | $764.00K 10-Q · filed 2016-07-27 | $877.00K derived: sum of 3 quarters · filed 2017-08-03 | $1.53M derived: sum of 4 quarters · filed 2017-08-03 | ||
| 2016-03-31 | $500.00K 10-Q · filed 2017-05-04 | $510.00K 10-Q · filed 2016-05-04 | $577.00K derived: sum of 2 quarters · filed 2017-05-04 | $1.23M derived: sum of 3 quarters · filed 2017-05-04 | $1.87M derived: sum of 4 quarters · filed 2017-05-04 | ||
| 2015-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $733.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.37M derived: sum of 3 quarters · filed 2017-03-16 | $2.05M 10-K · filed 2017-03-16 | |||
| 2015-09-30 | $656.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.29M derived: sum of 2 quarters · filed 2016-11-09 | $1.97M 10-Q · filed 2016-11-09 | $2.34M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $1.32M 10-Q · filed 2016-07-27 | $1.68M derived: sum of 3 quarters · filed 2017-03-16 | $1.88M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $684.00K 10-Q · filed 2016-05-04 | $1.05M derived: sum of 2 quarters · filed 2017-03-16 | $1.25M derived: sum of 3 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $567.00K derived: sum of 2 quarters · filed 2017-03-16 | $4.41M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $4.04M 10-Q · filed 2015-11-04 | |||||
| 2014-06-30 | $3.84M 10-Q · filed 2015-07-31 | ||||||
| 2013-12-31 | $4.76M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |